Background: Screening for colorectal cancer (CRC) reduces mortality, yet more than one third of age-eligible Americans are unscreened.
S
creening reduces colorectal cancer (CRC) incidence and mortality (1) . Several CRC tests have been shown to be cost-effective (2) (3) (4) (5) , and widely accepted guidelines recommend routine screening for adults starting at age 50 years (6 -8) . Despite broad support for CRC screening, more than one third of age-eligible Americans are unscreened, and CRC remains the second leading cause of cancer death in the United States (9, 10) .
Several barriers contribute to low screening rates. Some patients have negative attitudes about CRC tests or are unaware of the need for screening or the available tests (11) (12) (13) (14) (15) . Busy clinicians lack the time to fully discuss options and explore patient concerns (16, 17) . In addition, once patients leave the office, those who encounter difficulties preparing for or completing their screening tests receive little support.
Barriers to CRC screening are even greater in vulnerable populations, such as those with limited health literacy or low incomes (10, 18, 19) . More than one third of Americans have limited health literacy, or a decreased capacity to obtain, understand, and process health information (20, 21) . Such patients are less likely to understand medical information, ask questions, and receive preventive services (22, 23) . Accordingly, CRC screening rates are even lower among those with low health literacy, education, or income (24, 25) .
Decision aids that address patient knowledge and attitude barriers are a partial solution. However, they cannot overcome many provider and system barriers (26) . In our prior randomized controlled trial of a Webbased decision aid in vulnerable patients, the aid increased patients' desire to receive CRC screening, yet orders for and completion of screening tests increased by only 9 and 5 percentage points, respectively-differences that were not statistically significant (27) . To meaningfully increase CRC screening, additional efforts are needed that address these multilevel barriers and reach broadly across populations.
Recent increases in mobile device ownership create new opportunities for developing effective, efficient interventions. More than half of U.S. adults own a tablet device, more than three quarters own a smartphone, and 95% own a cell phone (28) . Cell phone ownership 
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is consistent across major sociodemographic groups (28) , giving interventions that incorporate text messaging broad reach.
To leverage patients' growing familiarity with mobile devices, we developed a digital health intervention for CRC screening that addresses patient, provider, and system barriers. The intervention, called Mobile Patient Technology for Health-CRC (mPATH-CRC), is an iPad (Apple) application that informs patients of the need for screening, helps them make a decision, lets them "selforder" a test, and sends automated electronic messages to help them complete that test. Patients use mPATH-CRC at their primary care provider's office on a device owned by the practice and can receive followup support on their own devices. We examined the efficacy of this tool in a socioeconomically diverse patient population.
METHODS
Design Overview
We did a parallel-design, randomized controlled trial to determine the effect of mPATH-CRC on receipt of screening within 24 weeks. Participants were enrolled between June 2014 and May 2016 and were assigned with equal probability to usual care or mPATH-CRC. Follow-up was completed in October 2016. Participants were told the study was being done "to determine the best way to teach people about important health topics." Study interviewers and outcome assessors were blinded to participant allocation. The Wake Forest Baptist Health Institutional Review Board approved the study, and all participants provided informed consent.
Setting and Participants
We did the study in 6 community-based primary care practices affiliated with a large academic health system in North Carolina. Three practices serve primarily urban and suburban populations, and 3 serve rural populations. The health system has a strong commitment to CRC screening. All practices share a common electronic health record (EHR) that notifies providers if screening is due.
We queried the EHR to identify English-speaking persons aged 50 to 74 years who were scheduled to see a primary care provider and were due for CRC screening. We excluded patients with a history of CRC or colonic polyps, a family history of CRC, recent rectal bleeding, a functional impairment preventing use of an iPad, or a medical condition predicting shorter life expectancy (dementia, recent treatment of cancer, advanced-stage cancer, or end-stage renal disease). A research assistant called patients to confirm eligibility and invite them to participate. Those who agreed were asked to arrive 45 to 60 minutes before their scheduled visit to enroll in the study and use the program.
Randomization and Interventions
The study program randomly assigned participants, stratified by site, to either mPATH-CRC or the control program with equal probability using variably sized permuted block randomization with random block sizes of 2 or 4. The random allocation sequences were generated by the study statistician using nQuery Advisor, version 7.0 (Statistical Solutions), and stored on each site's iPads in files accessible only by the study programmer. The largest clinic used 2 iPads, each with its own allocation sequence.
On the day of enrollment, participants met with a research assistant in a private room at their primary care clinic. The research assistant launched the study application on the iPad, which displayed the program determined by the randomization, then handed it to the participant and waited outside the door. After completing the assigned program, patients proceeded to their scheduled medical visits.
Details of the 2 programs (mPATH-CRC and the control program) and their usability were published previously (29) . Each program included identical baseline and postprogram self-administered surveys to collect demographic information and assess the shortterm outcomes described below. The survey estimated health literacy level using the single-item screening question, "How confident are you filling out medical forms by yourself?" (30) .
mPATH-CRC Program
Participants who interacted with mPATH-CRC viewed an 8.6-minute decision aid about CRC screening that had been previously validated and reviewed the 2 most commonly used tests, fecal testing for blood and colonoscopy (25, 31) . The mPATH-CRC program then let patients "order" their own screening test (fecal testing or colonoscopy). If a patient self-ordered a test, mPATH-CRC requested a cell phone number or e-mail address for follow-up electronic messages designed to help them complete the screening procedure.
When the participant finished, the program informed research staff of the patient's decision. If the patient ordered a test, the assistant immediately entered a cosignature-required order under the primary care provider's name in the EHR. In the Epic-based (Epic Systems) EHR used by study practices, any cosignaturerequired order is automatically sent to the provider's digital in-basket for approval or denial with a single click. The research assistant also attached a half-page flier to the patient's clinic paperwork to alert the primary care provider of the decision.
A separate series of electronic messages was developed for each of the 3 screening tests used (guaiacbased fecal occult blood testing, fecal immunochemical testing, and colonoscopy). A computerized protocol automatically sent messages with key information at specific times. For example, a message in the colonoscopy pathway delivered the day before the procedure encouraged patients to complete the bowel preparation and reminded them that they would need a driver. Patients could receive 3 to 10 messages, depending on the test ordered and their responses to the messages.
Control Program
The control program included a 4.3-minute video about diet and exercise produced by the Centers for A Digital Health Intervention for Colorectal Cancer Screening ORIGINAL RESEARCH Disease Control and Prevention (32) . Control participants were not given the option to self-order screening tests or receive follow-up electronic messages.
Outcomes and Follow-up
The next business day after the primary care visit, a research assistant called all participants to administer a telephone survey assessing whether they had discussed CRC screening with their provider and their satisfaction with any decisions made. A research assistant administered a final telephone survey to all participants 24 weeks after the visit, and study staff reviewed charts to determine whether CRC screening had been ordered and completed. If it was ordered but not completed, participants were asked why. All interviewers and outcome assessors were blinded to group assignment.
The primary outcome was chart-verified completion of a CRC screening test within 24 weeks of enrollment. Participants who reported being screened outside the health system on the final survey were asked for permission to obtain their records for verification. A second chart review was done for any patient not reached on the final survey or for disagreements between the final survey and initial chart review. Discrepancies were resolved by the consensus of a blinded adjudication committee. Fewer than 2% of participants (7 of 450) had discrepancies related to test completion. Secondary outcomes were assessed for all participants and included patient ability to state a screening preference and intention to receive screening as measured on the postprogram iPad survey. We determined ability to state a preference with the single item, "If you were going to be tested for colon cancer, which test would you want to have?" Possible answers included "stool test for blood," "colonoscopy," "I never want to be tested," and "I don't know enough to decide." Intention to receive screening was measured with the item, "Are you seriously thinking about getting tested for colon cancer?" with possible answers ranging from "Yes, within the next 30 days" to "No, I am not thinking of getting tested." Additional secondary outcomes included participant discussions of CRC screening with their provider (from the next-day telephone survey) and screening tests ordered (from chart review). Data on program usability, decision satisfaction, and costs were also collected but are not reported here.
Statistical Analysis
Our target sample size of 450 participants was chosen to detect a 12-percentage point difference in screening completion (20% vs. 32%) with 80% power at a 2-sided significance level of 5%. We did not adjust for loss to follow-up because the primary outcome was determined by chart review. 
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We used logistic regression to assess the effect of mPATH-CRC on screening completion. Because our study was randomized and stratified by clinic, the primary model included only the intervention group and clinic site as covariates. Simple chi-square tests were used to assess group differences in the secondary outcomes. We estimated the intervention effect as the difference in proportions with corresponding CIs. These analyses were also used to assess differences in other independent groups, such as test completion rates for ordered fecal tests versus ordered colonoscopies.
Only 5 demographic questions on the selfadministered survey had some responses of "don't know" or missing data. The number of missing responses ranged from 1 (0.2%) for cell phone ownership to 15 (3.3%) for date of last routine health checkup. These data were not used in the primary analysis. We purposefully designed mPATH-CRC for use in populations prone to health disparities (29) . Therefore, we did subgroup analyses of the effect of mPATH-CRC in those with low income (<$20 000 per year), limited literacy, and black or African American race. Logistic regression was used to assess the interactions of intervention group with income, literacy, and race. All analyses were done using SAS, version 9.4 (SAS Institute), with 2-sided tests and an ␣ level of 0.05. Procedures used included PROC FREQ with the RISKDIFF option for assessing unadjusted differences and PROC LOGISTIC for assessing the difference in the primary outcome adjusted for clinic.
Role of the Funding Source
The study received funding and support from the National Cancer Institute, the Wake Forest Clinical and Translational Science Institute study coordinator pool, and the shared resources provided by the Wake Forest Comprehensive Cancer Center. The funding organiza- (22) 102 (23) mPATH-CRC = Mobile Patient Technology for Health-Colorectal Cancer. * A few participants responded "don't know" or skipped some items on the self-administered surveys. Values are numbers (percentages) unless otherwise indicated. Percentages may not sum to 100 due to rounding. † mPATH-CRC group, n = 214; control group, n = 223. ‡ mPATH-CRC group, n = 223; control group, n = 226. § mPATH-CRC group, n = 222; control group, n = 223. ͉͉ mPATH-CRC group, n = 217; control group, n = 218. ¶ mPATH-CRC group, n = 219; control group, n = 222. ** Defined by a Rural-Urban Continuum code ≥4 (33).
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tions had no role in study conduct, manuscript preparation, or the decision to submit the manuscript for publication.
RESULTS
Research assistants screened 1183 patients to identify 640 eligible persons, of whom 450 enrolled (Figure) . Approximately half (n = 223) were randomly assigned to mPATH-CRC and half (n = 227) to the control program. All participants completed the assigned iPad programs, including the embedded surveys. Almost all participants completed the 24-week follow-up survey (86% [192 of 223] for mPATH-CRC and 90% [204 of 227] for control). Research staff blinded to randomization reviewed charts for all 450 participants.
Enrolled participants (median age, 57 years; range, 50 to 74 years) were racially and socioeconomically diverse. Overall, 38% of participants self-identified as African American, 37% had limited health literacy, and 53% had annual household incomes less than $20 000. Patient characteristics were similar between the 2 groups ( Table 1) .
Screening Test Completion
Participants in the mPATH-CRC group were twice as likely as control participants to complete a screening test (30% The odds ratio for completing screening was 2.5 (CI, 1.6 to 4.0) in favor of mPATH-CRC after accounting for the stratification factor (clinic). Results were fairly consistent across clinics (P for interaction = 0.82). Only 1 clinic had an intervention effect less than 13% ( Table 2) . Table 2 shows screening rates stratified by health literacy level, income, and race/ethnicity. Although not always statistically significant because of reduced sample sizes, screening rates consistently favored mPATH-CRC in all subgroups. We found no statistically significant interaction between the intervention and health literacy, income, or race/ethnicity.
Detection rates for colorectal neoplasia were 2.6% in the control group (6 adenomas) and 7.2% in the mPATH-CRC group (15 For participants who did not complete a fecal test, the most commonly cited reasons were losing or not having the kit (22%), not wanting to complete the kit or finding it embarrassing or distasteful (13%), forgetting to complete the kit (11%), and difficulty adhering to required dietary or medication restrictions (11%).
In the mPATH-CRC group, 118 participants ordered screening tests via the program, and 81% of these (96 of 118) signed up for follow-up e-mail or text 
DISCUSSION
In this randomized controlled trial, the mPATH-CRC digital health program doubled the proportion of patients who completed CRC screening, primarily because of an increase in test orders. Two components of mPATH-CRC directly encourage screening orders: the decision aid, which increases patients' intention to receive screening, and the ability to self-order tests, which decreases barriers to order entry. We previously studied the decision aid alone in a similar population and found that although patients' intention to receive screening increased, test ordering and completion increased only by a non-statistically significant 9 and 5 percentage points, respectively (27) . In contrast, in this current trial combining the decision aid with system interventions, test orders increased by 37 percentage points and test completion by 15 percentage points. This magnitude of effect is consistent with prior findings that system-level and structural changes often result in the greatest increases in CRC screening (34) .
Time constraints are cited as a major barrier to delivering preventive services (17, 35) . We designed mPATH-CRC to save time for providers and staff by empowering patients to order their own screening outside a medical encounter. Widespread adoption of mPATH-CRC could allow clinicians to spend their time more efficiently and effectively. Half of mPATH-CRC participants self-ordered a test via the program, obviating or reducing the amount of clinical time required to discuss options and order tests. Novel interventions like mPATH-CRC can serve as visit extenders, offloading routine tasks from the clinical encounter for patients who are comfortable and capable of managing a preventive care need.
Most CRC screening in the United States is done with colonoscopy (25), but patients who used mPATH-CRC were as likely to choose a fecal test, a result consistent with other studies of patient preference. In survey studies, one third to one half of patients chose fecal testing as their preferred screening option (36, 37) . In contrast, an analysis of more than 400 audio-recorded provider-patient discussions of CRC screening showed that 99% of providers favored colonoscopy and only 4% asked about patient preferences (38) . Therefore, it is not surprising that patients are more likely to receive the test their physician wants than the one they want (39) . However, patients are more likely to complete screening when given a choice (40). Population-based interventions like mass mailing of fecal test kits fail to offer a choice and require annual completion to remain effective. Decision aids, such as that included in mPATH-CRC, are a valuable tool for ensuring that patients are aware of their options.
The gap between the number of tests ordered and completed indicates that sending text messages or e-mails to help patients complete screening had a smaller effect. Both mPATH-CRC and control participants completed approximately half of all ordered screening tests. Overall, participants were more likely to complete a colonoscopy than a fecal test, a result we found surprising. This difference could indicate an increased commitment to screening among patients choosing colonoscopy, or it could reflect the routine telephone reminders that patients receive before colonoscopy appointments. A recent study found that a CRC screening decision aid coupled with patient navigation significantly increased screening, most of which was done with fecal testing (41) . Adding basic navigation support for patients who do not return their test kits may yield higher screening rates than we observed.
The mPATH-CRC application currently runs outside the EHR, allowing it to be used in any practice but also requiring staff to manually enter scheduled colonoscopy dates into the text-messaging platform. Updated data-exchange standards, such as Fast Healthcare Interoperability Resources (HL7) and application programming interfaces, will make integrating mPATH-CRC with EHRs easier in the future (42).
Two features of our study may have limited the difference in screening rates between groups. First, for most of the study, the clinics used guaiac-based fecal occult blood testing rather than the newer fecal immunochemical tests, which have simpler collection procedures and higher completion rates (43) . Second, our use of patient-level randomization may have caused some contamination, leading to higher screening rates in the control group. Therefore, our estimate of the effect of mPATH-CRC on screening is likely conservative.
Selection bias could also have affected our results because recruited patients had to agree to arrive at the clinic early to enroll. In addition, the postprogram survey assessing preferences may have triggered some patients to discuss CRC screening with their providers. However, both of these biases would be similar between groups. Although 90% of self-ordered tests were enacted by providers, we cannot determine why pro- A Digital Health Intervention for Colorectal Cancer Screening ORIGINAL RESEARCH viders changed some requests. Lastly, our study was done in a single large health system and was limited to English-speaking patients. In summary, mPATH-CRC doubled the proportion of patients who completed CRC screening. Although screening increased substantially in this study that included many persons with low income and limited health literacy, approximately half of patients did not complete their ordered tests. Incorporating more strategies to help patients complete their tests could further increase the effectiveness of mPATH-CRC. Future research should identify methods for implementing digital health interventions like mPATH-CRC into clinical care.
